GODREJAGRO Godrej Agrovet Q3 FY25 results (Oct–Dec 2024) and concall
Godrej Agrovet reported a quarter of strong profit growth driven by significant margin expansion in its Animal Feed and Vegetable Oil businesses. While overall revenue growth was moderate, operational efficiencies and favorable commodity prices boosted profitability. However, the company faced challenges in its Crop Protection segment and significantly revised down its full-year growth guidance for the Astec LifeSciences CDMO business to flat, citing customer-side postponements. Management also acknowledged investor concerns about the conglomerate structure and hinted at a potential future sim
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 1,848 | 1,869 |
| EBITDA | 222 | 195 |
| Net profit | 132 | 166 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
